These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3096897)

  • 1. Efficacy of a combined treatment with plasma exchange and cytostatics in macroglobulinemia.
    Busnach G; Dal Col A; Brando B; Perrino ML; Brunatti C; Minetti L
    Int J Artif Organs; 1986 Jul; 9(4):267-70. PubMed ID: 3096897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
    Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
    J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum immunoglobulins by protein electrophoresis and rate nephelometry before and after therapeutic plasma exchange.
    Filomena CA; Filomena AP; Hudock J; Ballas SK
    Am J Clin Pathol; 1992 Aug; 98(2):243-8. PubMed ID: 1510038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange and moderate dose of cytostatics in advanced macro(cryo)globulinemia. A report on three cases.
    Pihlstedt P
    Acta Med Scand; 1982; 212(3):187-90. PubMed ID: 6816017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Waldenström macroglobulinemia: a review of therapy.
    Gertz MA
    Am J Hematol; 2005 Jun; 79(2):147-57. PubMed ID: 15929102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of allergic vascularitis].
    de Leval-Rutten F
    Rev Med Liege; 1974 Feb; 29(4):102-4. PubMed ID: 4211106
    [No Abstract]   [Full Text] [Related]  

  • 7. [Waldenström's macroglobulinemia].
    Brouet JC
    Rev Prat; 1979 Jan; 29(3):317-20, 323-4, 329. PubMed ID: 105399
    [No Abstract]   [Full Text] [Related]  

  • 8. [Macroglobulinemia: report on 11 patients].
    Bonilla Velasco FA; Durantez Martínez A
    Rev Clin Esp; 1978 Feb; 148(3):279-84. PubMed ID: 418467
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines on the management of Waldenström macroglobulinaemia.
    Johnson SA; Birchall J; Luckie C; Oscier DG; Owen RG;
    Br J Haematol; 2006 Mar; 132(6):683-97. PubMed ID: 16487169
    [No Abstract]   [Full Text] [Related]  

  • 10. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
    Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
    J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waldenström macroglobulinemia.
    Gertz MA
    Hematology; 2012 Apr; 17 Suppl 1():S112-6. PubMed ID: 22507796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Waldenstrom's disease associated with Sjögren's syndrome. Double IgM population (lambda and kappa). Response to chlorambucil].
    Becq-Giraudon B; Yver L; Sudre Y; Hurez D; Gombert J; Alcalay D
    Nouv Presse Med; 1976 Jan; 5(3):137-8. PubMed ID: 817261
    [No Abstract]   [Full Text] [Related]  

  • 13. [Leukeran in treatment of macroglobulinemia].
    Bromberg-Sznek S; Szulkin E; Wolańska A
    Pol Tyg Lek; 1971 Aug; 26(32):1242-3. PubMed ID: 4999600
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.
    Leblond V; Johnson S; Chevret S; Copplestone A; Rule S; Tournilhac O; Seymour JF; Patmore RD; Wright D; Morel P; Dilhuydy MS; Willoughby S; Dartigeas C; Malphettes M; Royer B; Ewings M; Pratt G; Lejeune J; Nguyen-Khac F; Choquet S; Owen RG
    J Clin Oncol; 2013 Jan; 31(3):301-7. PubMed ID: 23233721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macroglobulinemia of Waldenström diagnosis and management.
    Messmore HL; Fareed J; Silberman S; Gawlik GM; Bermes EW
    Ann Clin Lab Sci; 1978; 8(4):310-7. PubMed ID: 99073
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of Waldenstrom's macroglobulinemia].
    Mokeeva RA
    Sov Med; 1976 Aug; (8):33-8. PubMed ID: 827026
    [No Abstract]   [Full Text] [Related]  

  • 17. Current treatment options for Waldenström macroglobulinemia.
    Vijay A; Gertz MA
    Clin Lymphoma Myeloma; 2008 Aug; 8(4):219-29. PubMed ID: 18765309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waldenström's macroglobulinemia: review of 45 cases.
    Krajny M; Pruzanski W
    Can Med Assoc J; 1976 May; 114(10):899-900, 902, 905. PubMed ID: 817791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Waldenstrom macroglobulinemia].
    Kolyvanos Naumann U; Käser L; Vetter W
    Praxis (Bern 1994); 2004 Mar; 93(14):547-52, 577. PubMed ID: 15125068
    [No Abstract]   [Full Text] [Related]  

  • 20. Waldenstrom's macroglobulinemia: a retrospective analysis of 40 patients from 1972 to 2001.
    Ngan S; Rohatiner AZ; Matthews J; Williams A; Amess JA; Norton A; Lister TA
    Semin Oncol; 2003 Apr; 30(2):236-8. PubMed ID: 12720143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.